Treatment of relapsing or recalcitrant cutaneous T-cell lymphoma with pegylated liposomal doxorubicin
- 1 January 2000
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 42 (1), 40-46
- https://doi.org/10.1016/s0190-9622(00)90007-0
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-hodgkin's lymphomaCancer, 1998
- Phase II Study of Mitoguazone, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone for Patients with Diffuse Histologic Subtypes of Non-Hodgkin's Lymphoma: An Eastern Cooperative Oncology Group Study (PE481)Leukemia & Lymphoma, 1998
- Systemic Poly chemotherapy in the Treatment of Primary Cutaneous Lymphomas: a Clinical Follow-Up Study of 81 Patients Treated with COP or CHOPLeukemia & Lymphoma, 1998
- Clinical Stage IA (Limited Patch and Plaque) Mycosis FungoidesArchives of Dermatology, 1996
- Mycosis fungoides and Sezary syndrome [see comments]Blood, 1996
- Cutaneous T-cell lymphoma (mycosis fungoides)The Lancet, 1996
- A Rational Approach to the Therapy of Cutaneous T–Cell LymphomasOncology Research and Treatment, 1996
- A Randomized Trial Comparing Combination Electron-Beam Radiation and Chemotherapy with Topical Therapy in the Initial Treatment of Mycosis FungoidesThe New England Journal of Medicine, 1989
- Histopathologic Staging at Initial Diagnosis of Mycosis Fungoides and the Sézary SyndromeAnnals of Internal Medicine, 1988
- Adriamycin therapy in advanced mycosis fungoidesCancer, 1977